Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Data solutions
Index solutions
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (2)
More (2)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Precision NeuroscienceHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$182.65MMSeries C12/16/2024$102MM$542.69MM$5.70General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital
SynthegoHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$415.07MMSeries E2/17/2022$144.17MM$1.3B$10.78Perceptive Advisors, SoftBank, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund, Chimera Abu Dhabi, Wellington Management, RA Capital Management, Moore Strategic Ventures
Arbor BiotechnologiesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$331.59MMSeries C-210/8/2025$26.09MM$282.07MM$4.52Undisclosed Investors
ArineHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$66.04MMSeries C6/24/2025$30MM$494.87MM$15.42Town Hall Ventures, Kaiser Permanente Ventures
CellibreHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
Element BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$1.5BSeries D-17/11/2024$138.5MM$1.05B$7.84Wellington Management, Samsung Electronics, Fidelity, Foresite Capital, T. Rowe Price Associates, Venrock
KardiganHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$554MMSeries B-110/14/2025$78.31MM$1.11B$21.37Fidelity, T. Rowe Price, ARCH Venture Partners, Sequoia Heritage
Sound PharmaceuticalsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$25.95MMSeries C-25/24/2018$11.76MM$47.84MM$3.00Undisclosed Investors
Twin HealthHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$304.72MMSeries E8/21/2025$53MM$950MM$13.85Maj Invest, Temasek, ICONIQ Growth
Zenas BioPharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
ArcellxHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$235.48MMSeries C4/13/2021$120MM$377.76MM$2.10Samsara BioCapital, CAM Capital, Adage, Asymmetry, CaaS Capital, Cambrian Bio, Sixty Degree, Soleus Capital, Surveyor Capital, Suvretta, Terra Magnum Capital Partners, New Enterprise Associates, Novo Holdings, SR One, Takeda Ventures, LG Tech, Clough Capital
BlueRock TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
CambrianHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$299.72MMSeries C10/26/2021$100.78MM$486.23MM$6.95Anthos Capital, SALT Fund, Apeiron Investment Group, Future Ventures, Moore Capital
Candid TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$370MMSeries B9/9/2024$190.26MM$660.51MM$1.20Venrock, Fairmount Partners, TCG Crossover Management, venBio Partners, Foresite Capital, Third Rock Ventures, Fidelity, Samsara BioCapital, Qiming Venture Partners, OrbiMed, Boxer Capital, Redmile Group, Vida Ventures, Two River, Franklin Templeton, LifeSci Venture Partners, Mirae Asset Capital Life Science, Polaris Partners, Soleus Capital
Cognito TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
Ginkgo BioworksHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$785.53MMSeries E5/28/2020$360MM$4.89B$150.19T. Rowe Price, Allen & Company, Baillie Gifford, Cascade Investment, General Atlantic, Reshape Holdings, Viking Global Investors, Illumina
Kailera TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$959.96MMSeries B10/14/2025$603.18MM$1.4B$14.00Bain Capital, Adage Capital Management, Canada Pension Plan Investment Board, Invus, Janus Henderson Investors, Perseverance Capital, QIA, Royalty Pharma, Surveyor Capital, T. Rowe Price, Atlas Venture, Bain Capital Life Sciences, RTW Investments, Sirona Capital
MedableHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$530.96MMSeries D10/26/2021$304.88MM$2.1B$9.67Blackstone Growth, Tiger Global, GSR Ventures, Sapphire Ventures, WTI
Prime MedicineHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$315.76MMSeries B7/13/2021$200MM$1.23B$4.38ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, Public Sector Pension Investment Board, Redmile Group, Samsara BioCapital, T. Rowe Price
ResilienceHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$4.18BSeries D6/6/2022$625MM$8.84B$60.73Undisclosed Investors
SetPoint MedicalHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$303.01MMSeries D8/11/2025$115MM$471.62MM$1.51Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest Venture Partners, New Enterprise Associates, Viking Global Investors, Action Potential Venture Capital, Abbott, Boston Scientific, Euclidean Capital, Richard King Mellon Foundation, Morgenthaler Ventures, ShangBay Capital, Ascendum Capital, Catalio Capital Management, Gilmartin Capital, Midas Capital
Accutar BiotechnologyHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$207.47MMSeries B+48/20/2021$80MM$987.52MM$77.58Undisclosed Investors
ArsenalBioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$2.44BSeries C9/4/2024$327.5MM$1.66B$18.58ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVIDIA, Luma Group, T. Rowe Price Associates, Rock Springs Capital, Parker Institute for Cancer Immunotherapy, SoftBank, Bristol-Myers Squibb, Westlake Village BioPartners, Kleiner Perkins, Byers Capital, Hitachi Ventures
Bicara TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$710.05MMSeries C12/12/2023$165MM$495.55MM$1.38Braidwell LP, TPG, The Rise Fund, Deerfield Management, Fairmount, Aisling Capital, Red Tree Venture Capital, RA Capital Management, F-Prime Capital, Eight Roads Ventures, Invus Piper Heartland Healthcare Capital, Premji Invest, Omega Funds, Bioqube Ventures, Acorn Bioventures, Janus Henderson Investors
49-72 of 471

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.